Using patients' own blood to reduce transfusion needs after heart surgery
Official title: The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery (TheRAPy): a Multiple Period Vanguard Cluster Crossover Trial
Run by Population Health Research Institute · NCT06230198 · Data updated 2026-11-12
This study is testing whether using patients' own blood during heart surgery can help reduce the need for blood transfusions compared to the usual method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 110 Years |
| Sex | All |
| Enrollment | 4500 (estimated) |
| Sponsor | Population Health Research Institute Academic / other |
| Locations | 4 sites (Winnipeg, Manitoba and 3 other locations) |
| Status | Recruiting |
| Started | December 4, 2024 |
| Main results expected | January 2026 |
| Study ends | November 2026 |
| Registry record updated | March 4, 2025 |
| Trial ID | NCT06230198 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults undergoing cardiac surgery on cardiopulmonary bypass at participating hospitals.
✕Probably not a fit
Patients undergoing cardiac surgery at hospitals with fewer than 200 cases per year or where the surgical team does not agree to the trial protocols may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the feasibility of implementing a routine practice of retrograde autologous priming (RAP) compared to traditional crystalloid priming during cardiac surgeries. By using patients' own blood to prime the heart-lung machine, the study aims to minimize red blood cell (RBC) loss and reduce the need for transfusions. Conducted across four hospitals, the trial will alternate between the two priming methods over 12 periods, involving approximately 4500 cardiac surgery patients. The results will inform whether a larger trial is warranted to confirm the benefits of RAP in reducing transfusion requirements.
Why it matters
Potential benefit: If successful, this approach could significantly decrease the need for RBC transfusions in cardiac surgery patients, improving patient outcomes and conserving blood resources.
How similar studies have gone: Previous smaller studies have shown that RAP can reduce RBC transfusions by significant margins, suggesting potential success for this larger trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitals completing \>200 adult cardiac surgical cases a year; (ii) 95% of cardiovascular surgery group (i.e., cardiac anesthesiologists, surgeons, and perfusionists) agree to manage patients under both autologous priming policies as per their randomization schedule for the duration of the trial. * All patients undergoing cardiac surgery on cardiopulmonary bypass at an enrolled site during the trial period will be included in data collection. Exclusion Criteria: * Complete \<=200 cardiac surgical cases. * \<95% of their cardiovascular surgery group agrees to manage patients according to either of the two policies.
Where it's running
-
St. Boniface Hospital
Winnipeg, Manitoba, Canada Recruiting -
Hamilton General Hospital
Hamilton, Ontario, Canada Recruiting -
Montreal Heart Institute
Montreal, Quebec, Canada Recruiting -
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Jessica Spence, MD, PhD — Population Health Research Institute
- Study coordinator: TheRAPy Study Coordinator
- Email: therapy@phri.ca
- Phone: 9055212100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Head-of-bed position after clot-removal stroke therapy
This study tests whether keeping the head of the bed flat (0 degrees) after thrombectomy improves recovery compared with a raised position in adults who had an ischemic stroke due to large vessel blockage.
-
Monitoring heart rhythm after noncardiac surgery
This study is testing if wearing a portable heart monitor for up to 14 days after noncardiac surgery can help find heart rhythm problems that are often missed, to improve care for patients.
-
Registry for Calcium Release Deficiency Syndrome
This study is trying to gather information about Calcium Release Deficiency Syndrome to better understand it and find the best ways to treat people with this heart condition caused by RYR2 gene changes.
-
Surgical procedure to prevent heart rhythm issues after cardiac surgery
This study is testing a surgical procedure to see if it can help prevent heart rhythm problems after heart surgery for patients who haven't had these issues before.
-
Evaluating a diagnostic test for Calcium Release Deficiency Syndrome
This study is testing a new way to diagnose Calcium Release Deficiency Syndrome by looking at how the heart responds to fast pacing, aiming to make diagnosis easier for patients with this condition and similar heart issues.
-
Short-term treatment with amiodarone for new atrial fibrillation after heart surgery
This study is testing whether a short-term treatment with amiodarone can help people who develop new atrial fibrillation after heart surgery feel better and keep their heart rhythm stable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.